Genta (correction)
Executive Summary
Genta Genasense (oblimersen) front-line trial in malignant melanoma randomizes 750 patients to Genasense plus dacarbazine or dacarbazine alone. "The Pink Sheet" incorrectly reported the design (March 10, p. 21)...